Private equity firm Carlyle Group Inc has entered into exclusive negotiations to acquire a majority stake in two medical device businesses of Medtronic Plc at a valuation of more than $7 billion, according to people familiar with the matter. Were an agreement to be reached in the coming weeks, it would mark the culmination of
Business * Private equity firm Carlyle Group Inc has entered into exclusive negotiations to acquire a majority stake in two medical device businesses of Medtronic Plc at a valuation of more than $7 billion, according to people familiar with the matter.
Were an agreement to be reached in the coming weeks, it would mark the culmination of Medtronic’s src2-month review of its patient monitoring and respiratory interventions businesses, that it also considered spinning off into a standalone public company.
Medtronic is seeking to streamline its portfolio and focus on its higher-growth assets, such as its heart and diabetes
See original post – Read More